Stay Updated
Press Releases
WASHINGTON, D.C. — Patients For Affordable Drugs welcomes the Centers for Medicare & Medicaid Services (CMS) statement today reaffirming the continuation of Medicare drug price negotiation. P4AD Founder and President, David Mitchell, released the following statement in response: “We are very pleased to see the Medicare prescription drug program move forward under the Trump Administration. […]
Press Releases
P4AD Pushes Back On Pharmaceutical Company Claims, Highlights The Drug Industry’s Decades-Long Prohibition On Medicare’s Ability To Negotiate Lower Drug Prices, And Amplifies The Experiences Of Patients WASHINGTON, D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals in the Second Circuit, defending the Medicare negotiation program […]
Press Releases
Patients For Affordable Drugs Celebrates Another Critical Step Forward in the Fight Against Skyrocketing Prescription Costs WASHINGTON, D.C. — The Centers for Medicare & Medicaid Services (CMS) has the 2024 milestone, when prices were successfully negotiated for the first 10 drugs under the 2022 prescription drug law, this expansion marks another major step toward ensuring […]
Press Releases
This Marks The 10th Lawsuit Filed By Pharma And Its Allies To Undermine Medicare Drug Price Negotiation At the Expense Of Patients WASHINGTON, D.C. — On the verge of the announcement of the next 15 drugs selected for Medicare drug price negotiations, Teva Pharmaceuticals filed a lawsuit in the U.S. District Court for the District […]
Press Releases
ICYMI: Patients On Medicare Celebrate $2,000 Cap On Out-Of-Pocket Costs
Millions Of Patients Anticipate Substantial Savings As New Limit On Annual Out-of-Pocket Costs Goes Into Effect January 1st WASHINGTON, D.C. — Starting this week, everyone with Medicare Part D will have their annual out-of-pocket drug costscappedat $2,000. This historic reform is one of the most substantial provisions from the 2022 prescription drug price law to […]
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation at the Expense of Patients WASHINGTON D.C. — Patients For Affordable Drugs filed a 29-page amicus brief today in the U.S. Court of Appeals for the Third Circuit, defending Medicare’s authority to negotiate lower drug prices in a […]
Press Releases
Patients For Affordable Drugs Continues to Fight Against Big Pharma’s Attempts to Undermine Medicare Drug Price Negotiation at the Expense of Patients WASHINGTON D.C. — Oral arguments were heard today by the United States Court of Appeals for the Third Circuit in the consolidated cases brought by Bristol Myers-Squibb (BMS), AstraZeneca, and Janssen Pharmaceuticals challenging […]
Press Releases
Judge Upholds Medicare’s Drug Price Negotiation Program, Dealing Another Blow to Pharmaceutical Industry Lawsuits WASHINGTON D.C. — Marking the eighth win in the ongoing legal battle to preserve the Medicare Negotiation Program, on Friday, October 18th, a district court judge in New Jersey rejected Novartis’ lawsuit against the drug price negotiation program. This ruling adds […]